Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$687K Sell
12,686
-7,965
-39% -$444K 0.75% 42
2014
Q3
$1.17M Sell
20,651
-220
-1% -$12.4K 0.5% 47
2014
Q2
$1.15M Sell
20,871
-94
-0.4% -$5.13K 0.48% 47
2014
Q1
$1.14M Sell
20,965
-142
-0.7% -$7.35K 0.49% 45
2013
Q4
$1.01M Buy
21,107
+163
+0.8% +$7.45K 0.46% 47
2013
Q3
$951K Sell
20,944
-110
-0.5% -$5.02K 0.48% 50
2013
Q2
$933K Buy
+21,054
New +$940K 0.51% 44

Other funds holding MRK

Michael B. Elefante's MRK Position: Q4 2014 in Review

Michael B. Elefante reduced its Merck (MRK) stake by 39% in Q4 2014, selling an estimated $444K and leaving 12,686 shares worth $687K. The position accounts for 0.75% of the portfolio, ranked #42.

Michael B. Elefante first reported a position in MRK in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.17M in Q3 2014. 1,723 funds tracked by Wall St. Rank hold MRK as of Q4 2014.

  • Michael B. Elefante held 12,686 shares of Merck worth $687K as of Q4 2014.
  • Michael B. Elefante sold 7,965 Merck shares in Q4 2014, an estimated $444K.
  • Merck made up 0.75% of Michael B. Elefante's portfolio in Q4 2014, its #42 holding.
  • Michael B. Elefante first reported a position in Merck in Q2 2013 and has held it in 7 quarters since.
  • Michael B. Elefante's Merck position peaked at $1.17M in Q3 2014.
  • 1,723 funds tracked by Wall St. Rank held Merck as of Q4 2014.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.